Labiana Health S.A. (LAB) - Total Liabilities
Based on the latest financial reports, Labiana Health S.A. (LAB) has total liabilities worth €52.79 Million EUR (≈ $61.71 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Labiana Health S.A. (LAB) asset resilience to evaluate the company's liquid asset resilience ratio.
Labiana Health S.A. - Total Liabilities Trend (2021–2025)
This chart illustrates how Labiana Health S.A.'s total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see LAB current and non-current assets.
Labiana Health S.A. Competitors by Total Liabilities
The table below lists competitors of Labiana Health S.A. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bilendi
PA:ALBLD
|
France | €100.55 Million |
|
Oswal Greentech Limited
NSE:OSWALGREEN
|
India | Rs481.96 Million |
|
Wikana SA
WAR:WIK
|
Poland | zł112.73 Million |
|
The Investment Trust Of India Limited
NSE:THEINVEST
|
India | Rs2.63 Billion |
|
Payment Financial Technologies Ltd
TA:PMNT
|
Israel | ILA133.38 Million |
|
Gihon Telekomunikasi Indonesia Tbk PT
JK:GHON
|
Indonesia | Rp586.75 Billion |
|
Equus Energy Ltd
AU:EQU
|
Australia | AU$2.18 Million |
|
CHEET.M.ADR 50 NEW
F:0C9
|
Germany | €2.73 Billion |
Liability Composition Analysis (2021–2025)
This chart breaks down Labiana Health S.A.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is Labiana Health S.A.'s balance sheet to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.39 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 10.38 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.92 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Labiana Health S.A.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Labiana Health S.A. (2021–2025)
The table below shows the annual total liabilities of Labiana Health S.A. from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €52.79 Million ≈ $61.71 Million |
+6.78% |
| 2024-12-31 | €49.43 Million ≈ $57.79 Million |
-11.28% |
| 2023-12-31 | €55.72 Million ≈ $65.14 Million |
+5.06% |
| 2022-12-31 | €53.04 Million ≈ $62.00 Million |
-6.70% |
| 2021-12-31 | €56.84 Million ≈ $66.46 Million |
-- |
About Labiana Health S.A.
Labiana Health, S.A. develops, manufactures, sells, and markets animal and human health medicine products in Spain, rest of European Union, North America, and internationally. It offers anesthetics-sedatives, anti-infectives, anti-inflammatories, antiparasitics, hormonals, nutritional products, metabolism regulators, and vitamin products. The company also provides sterile and lyophilized dosage f… Read more